1015 related articles for article (PubMed ID: 16878047)
21. Trends and characteristics of all-cause mortality among HIV-infected inpatients during the HAART era (2006-2015) in Shanghai, China.
Ji Y; Wang Z; Shen J; Chen J; Yang J; Qi T; Song W; Tang Y; Liu L; Shen Y; Zhang R; Lu H
Biosci Trends; 2017 Mar; 11(1):62-68. PubMed ID: 28132999
[TBL] [Abstract][Full Text] [Related]
22. Temporal changes in causes of death among HIV-infected patients in the HAART era in Rio de Janeiro, Brazil.
Pacheco AG; Tuboi SH; May SB; Moreira LF; Ramadas L; Nunes EP; Merçon M; Faulhaber JC; Harrison LH; Schechter M
J Acquir Immune Defic Syndr; 2009 Aug; 51(5):624-30. PubMed ID: 19430304
[TBL] [Abstract][Full Text] [Related]
23. [Study on the mortality and risk factors among HIV/AIDS patients receiving antiretroviral therapy in Xinjiang Uygur Autonomous Region].
Ni M; Chen X; Hu X; Ma Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Nov; 48(11):953-8. PubMed ID: 25582364
[TBL] [Abstract][Full Text] [Related]
24. Higher risk of AIDS or death in patients with lower CD4 cell counts after virally suppressive HAART.
Taiwo BO; Li X; Palella F; Jacobson LP; Margolick JB; Detels R; Rinaldo CR; Phair JP
HIV Med; 2009 Nov; 10(10):657-60. PubMed ID: 19601997
[TBL] [Abstract][Full Text] [Related]
25. Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion.
Smit C; Geskus R; Walker S; Sabin C; Coutinho R; Porter K; Prins M;
AIDS; 2006 Mar; 20(5):741-9. PubMed ID: 16514305
[TBL] [Abstract][Full Text] [Related]
26. Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study.
Young J; De Geest S; Spirig R; Flepp M; Rickenbach M; Furrer H; Bernasconi E; Hirschel B; Telenti A; Vernazza P; Battegay M; Bucher HC;
BMJ; 2004 Jan; 328(7430):15. PubMed ID: 14703538
[TBL] [Abstract][Full Text] [Related]
27. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
; Sterne JA; May M; Costagliola D; de Wolf F; Phillips AN; Harris R; Funk MJ; Geskus RB; Gill J; Dabis F; Miró JM; Justice AC; Ledergerber B; Fätkenheuer G; Hogg RS; Monforte AD; Saag M; Smith C; Staszewski S; Egger M; Cole SR
Lancet; 2009 Apr; 373(9672):1352-63. PubMed ID: 19361855
[TBL] [Abstract][Full Text] [Related]
28. Changes in mortality related to human immunodeficiency virus infection: comparative analysis of inpatient deaths in 1995 and in 1999-2000.
Jain MK; Skiest DJ; Cloud JW; Jain CL; Burns D; Berggren RE
Clin Infect Dis; 2003 Apr; 36(8):1030-8. PubMed ID: 12684916
[TBL] [Abstract][Full Text] [Related]
29. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.
Martínez E; Milinkovic A; Buira E; de Lazzari E; León A; Larrousse M; Loncá M; Laguno M; Blanco JL; Mallolas J; García F; Miró JM; Gatell JM
HIV Med; 2007 May; 8(4):251-8. PubMed ID: 17461853
[TBL] [Abstract][Full Text] [Related]
30. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies.
Antiretroviral Therapy Cohort Collaboration
Clin Infect Dis; 2010 May; 50(10):1387-96. PubMed ID: 20380565
[TBL] [Abstract][Full Text] [Related]
31. Mortality and morbidity of HIV infected patients receiving HAART: a cohort study.
Panos G; Samonis G; Alexiou VG; Kavarnou GA; Charatsis G; Falagas ME
Curr HIV Res; 2008 May; 6(3):257-60. PubMed ID: 18473789
[TBL] [Abstract][Full Text] [Related]
32. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.
Lewden C; Salmon D; Morlat P; Bévilacqua S; Jougla E; Bonnet F; Héripret L; Costagliola D; May T; Chêne G;
Int J Epidemiol; 2005 Feb; 34(1):121-30. PubMed ID: 15561752
[TBL] [Abstract][Full Text] [Related]
33. Early mortality and cause of deaths in patients using HAART in Brazil and the United States.
Grinsztejn B; Veloso VG; Friedman RK; Moreira RI; Luz PM; Campos DP; Pilotto JH; Cardoso SW; Keruly JC; Moore RD
AIDS; 2009 Oct; 23(16):2107-14. PubMed ID: 19770698
[TBL] [Abstract][Full Text] [Related]
34. Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.
Marin B; Thiébaut R; Bucher HC; Rondeau V; Costagliola D; Dorrucci M; Hamouda O; Prins M; Walker S; Porter K; Sabin C; Chêne G
AIDS; 2009 Aug; 23(13):1743-53. PubMed ID: 19571723
[TBL] [Abstract][Full Text] [Related]
35. Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study.
Matinella A; Lanzafame M; Bonometti MA; Gajofatto A; Concia E; Vento S; Monaco S; Ferrari S
J Neurol; 2015 May; 262(5):1317-27. PubMed ID: 25877836
[TBL] [Abstract][Full Text] [Related]
36. [Sex specific mortality in HIV/AIDS patients receiving antiretroviral therapy and risk factors in Xinjiang Uygur autonomous region].
Ni M; Chen X; Ma Y; Hu X
Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Sep; 36(9):971-5. PubMed ID: 26814865
[TBL] [Abstract][Full Text] [Related]
37. Rate, causes, and clinical implications of presenting with low CD4+ cell counts in the era of highly active antiretroviral therapy.
Núñez M; Asencio R; Valencia ME; Leal M; González-Lahoz J; Soriano V
AIDS Res Hum Retroviruses; 2003 May; 19(5):363-8. PubMed ID: 12803995
[TBL] [Abstract][Full Text] [Related]
38. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.
Hogg RS; Yip B; Chan KJ; Wood E; Craib KJ; O'Shaughnessy MV; Montaner JS
JAMA; 2001 Nov; 286(20):2568-77. PubMed ID: 11722271
[TBL] [Abstract][Full Text] [Related]
39. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration.
Smith CJ; Ryom L; Weber R; Morlat P; Pradier C; Reiss P; Kowalska JD; de Wit S; Law M; el Sadr W; Kirk O; Friis-Moller N; Monforte Ad; Phillips AN; Sabin CA; Lundgren JD;
Lancet; 2014 Jul; 384(9939):241-8. PubMed ID: 25042234
[TBL] [Abstract][Full Text] [Related]
40. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L.
Wood E; Hogg RS; Yip B; Harrigan PR; O'Shaughnessy MV; Montaner JS
Ann Intern Med; 2003 Nov; 139(10):810-6. PubMed ID: 14623618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
